Tuberculosis (TB) patients will be screened for novel coronavirus disease (COVID-19) and those suffering from COVID-19 will likewise be screened for TB, according to new guidelines issued by the Union Ministry of Health and Family Welfare (MoHFW).
The guidelines in the wake of declining reportage of TB cases in the country, ever since COVID-19 was notified. “There has been an overall decline in TB notification by 26 per cent during January-June 2020, as compared to the previous year, due to the COVID-19 pandemic,” the guidelines said.
Various research studies have indicated significant prevalence of TB among COVID-19 patients. The prevalence of TB among COVID-19 patients ranges between 0.37-4.47 per cent, studies have shown.
The MoHFW guidelines have quoted unnamed studies that found “that history of active as well as latent TB is an important risk factor for SARS-CoV-2 infection”. Tuberculosis is associated with a 2.1-fold increased risk of severe COVID-19 disease, the guidelines document said.
For TB patients who are found COVID-19 positive, the treatment for both would be taken up. Similarly, COVID-19 patients screened for TB would undergo the same treatment for both.
The MoHFW has also asked governments to link facilities for TB and COVID-19 for better management of patients with both infections.